Evidence map›Paper›PMID 36968547›Full record

ArticleACS central science2023

Macrophage Inactivation by Small Molecule Wedelolactone via Targeting sEH for the Treatment of LPS-Induced Acute Lung Injury.

Juan Zhang, Min Zhang, Xiao-Kui Huo, Jing Ning, Zhen-Long Yu, Christophe Morisseau, Cheng-Peng Sun, Bruce D Hammock, Xiao-Chi Ma

Open access · diamondFull text read
In one paragraph

Article in ACS central science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
17.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 97 citations in OpenAlex.

  1. Theaflavin attenuates atherosclerosis by targeting GSK-3β to suppress pyroptosis and Promote Autophagy in macrophages.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Role for Non-Canonical Caspases in Fungal Allergic Airway Disease.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Targeting PBK with small-molecule 1-Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Juan ZhangCollege of Pharmacy, Dalian Medical University, Dalian 116044, China.
Min ZhangCollege of Pharmacy, Dalian Medical University, Dalian 116044, China.
Xiao-Kui HuoSecond Affiliated Hospital, Dalian Medical University, Dalian 116023, China.
Jing NingCollege of Pharmacy, Dalian Medical University, Dalian 116044, China.
Zhen-Long YuCollege of Pharmacy, Dalian Medical University, Dalian 116044, China.
Christophe MorisseauDepartment of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States.
Cheng-Peng SunCollege of Pharmacy, Dalian Medical University, Dalian 116044, China.ORCID https://orcid.org/0000-0001-6801-3439
Bruce D HammockDepartment of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, California 95616, United States.ORCID https://orcid.org/0000-0003-1408-8317
Xiao-Chi MaSecond Affiliated Hospital, Dalian Medical University, Dalian 116023, China.
Dalian Medical University · CNUC Davis Comprehensive Cancer Center

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Supplement for bioactive lipids as effectors and indicators of the deleterious effects of human healthR35ES030443 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MORISSEAU, CHRISTOPHE HP · 2019 to 2025
$5.8M
NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R35 ES030443
6 · The paper itself

Abstract

Soluble epoxide hydrolase (sEH) plays a critical role in inflammation by modulating levels of epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids (EpFAs). Here, we investigate the possible role of sEH in lipopolysaccharide (LPS)-mediated macrophage activation and acute lung injury (ALI). In this study, we found that a small molecule, wedelolactone (WED), targeted sEH and led to macrophage inactivation. Through the molecular interaction with amino acids Phe362 and Gln384, WED suppressed sEH activity to enhance levels of EETs, thus attenuating inflammation and oxidative stress by regulating glycogen synthase kinase 3beta (GSK3β)-mediated nuclear factor-kappa B (NF-κB) and nuclear factor E2-related factor 2 (Nrf2) pathways

Identifiers

PMID36968547
PMCPMC10037491
OpenAlexW4321436021

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read3
measurements read67
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.